| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | KINDRED HEALTHCARE INC | 97,215 | 812,000 | 0.38% | ||
| 2 | MOLINA HEALTHCARE INC | 20,000 | 912,000 | 0.42% | ||
| 3 | SEATTLE GENETICS INC | 15,000 | 943,000 | 0.44% | ||
| 4 | NEUROCRINE BIOSCIE COM USD0.001 | 25,000 | 1,083,000 | 0.50% | ||
| 5 | PUMA BIOTECHNOLOGY | 30,000 | 1,116,000 | 0.52% | ||
| 6 | BLUEBIRD BIO INC COM | 13,900 | 1,264,000 | 0.59% | ||
| 7 | CLOVIS ONCOLOGY INC | 20,000 | 1,273,000 | 0.59% | ||
| 8 | KITE PHARMA INCORPORATED | 18,000 | 1,413,000 | 0.66% | ||
| 9 | SAGE THERAPEUTICS INC | 20,000 | 1,421,000 | 0.66% | ||
| 10 | RESMED INC | 21,200 | 1,526,000 | 0.71% | ||
| 11 | TEVA PHARMACEUTICAL INDS LTD | 50,000 | 1,605,000 | 0.75% | ||
| 12 | DIPLOMAT PHARMACY INC COM | 101,000 | 1,611,000 | 0.75% | ||
| 13 | TESARO INCORPORATED | 10,500 | 1,616,000 | 0.75% | ||
| 14 | PERRIGO CO PLC | 25,000 | 1,660,000 | 0.77% | ||
| 15 | ILLUMINA INC | 10,000 | 1,706,000 | 0.79% | ||
| 16 | INTUITIVE SURGICAL INC | 2,250 | 1,725,000 | 0.80% | ||
| 17 | AMEDISYS INC COM | 34,607 | 1,768,000 | 0.82% | ||
| 18 | IMPAX LABORATORIES INC | 168,030 | 2,126,000 | 0.99% | ||
| 19 | SMITH & NEPHEW PLC | 70,000 | 2,165,000 | 1.01% | ||
| 20 | ACADIA COMPANY COM | 50,000 | 2,180,000 | 1.02% | ||
| 21 | VALEANT PHARMACEUTICALS INTL | 200,000 | 2,206,000 | 1.03% | ||
| 22 | PAREXEL INTERNATIONAL CORPORATION | 35,000 | 2,209,000 | 1.03% | ||
| 23 | ACADIA PHARMACEUTICALS INC COM | 65,000 | 2,235,000 | 1.04% | ||
| 24 | MYLAN N V | 60,000 | 2,339,000 | 1.09% | ||
| 25 | BARD C R INC | 10,000 | 2,485,000 | 1.16% | ||
| 26 | LHC GROUP INC | 49,405 | 2,663,000 | 1.24% | ||
| 27 | CHEMED CORP NEW COM | 15,000 | 2,740,000 | 1.28% | ||
| 28 | CARDINAL HEALTH INC | 35,000 | 2,854,000 | 1.33% | ||
| 29 | BECTON DICKINSON & CO | 20,000 | 3,669,000 | 1.71% | ||
| 30 | THERMO FISHER SCIENTIFIC INC | 25,000 | 3,840,000 | 1.79% | ||
| 31 | ASTRAZENECA PLC | 125,000 | 3,893,000 | 1.81% | ||
| 32 | AMERISOURCEBERGEN CORP | 45,000 | 3,983,000 | 1.85% | ||
| 33 | TENET HEALTHCARE CORP | 225,000 | 3,985,000 | 1.86% | ||
| 34 | BIOGEN INC | 15,000 | 4,101,000 | 1.91% | ||
| 35 | BRISTOL MYERS SQUIBB CO | 77,400 | 4,209,000 | 1.96% | ||
| 36 | GW PHARMACEUTICALS PLC | 35,200 | 4,257,000 | 1.98% | ||
| 37 | ABBOTT LABS | 100,000 | 4,441,000 | 2.07% | ||
| 38 | MCKESSON CORP | 30,000 | 4,448,000 | 2.07% | ||
| 39 | CENTENE CORP DEL | 65,000 | 4,632,000 | 2.16% | ||
| 40 | HCA HOLDINGS INC | 52,500 | 4,672,000 | 2.18% | ||
| 41 | AGILENT TECHNOLOGIES INC | 90,000 | 4,758,000 | 2.22% | ||
| 42 | MERCK & CO INC | 75,000 | 4,766,000 | 2.22% | ||
| 43 | BIOMARIN PHARMACEUTICAL INC | 55,000 | 4,828,000 | 2.25% | ||
| 44 | ZIMMER BIOMET HLDGS INC | 40,000 | 4,884,000 | 2.27% | ||
| 45 | BOSTON SCIENTIFIC CORP | 200,000 | 4,974,000 | 2.32% | ||
| 46 | PERKINELMER INC | 90,000 | 5,225,000 | 2.43% | ||
| 47 | UNIVERSAL HLTH SVCS INC | 42,500 | 5,289,000 | 2.46% | ||
| 48 | VERTEX PHARMACEUTICALS INC | 50,000 | 5,468,000 | 2.55% | ||
| 49 | BAXTER INTL INC | 110,000 | 5,705,000 | 2.66% | ||
| 50 | CELGENE CORP | 47,500 | 5,910,000 | 2.75% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001398344-17-006221, filed 2017.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
